NEW YORK, NY / ACCESSWIRE / May 25, 2018 / U.S. markets were weighed down by the energy sector on Thursday as U.S. crude oil prices closed lower for the third consecutive session. However, major indexes received a boost after President Trump announced the cancellation of a planned summit with North Korean leader Kim Jong Un. The Dow Jones Industrial Average dropped 0.30 percent to close at 24,811.76, while the S&P 500 Index declined 0.20 percent to close at 2,727.76. The Nasdaq Composite Index fell 0.02 percent to close at 7,424.43.
"The selloff after the cancellation of the North Korea meeting was muted, largely because it doesn't change the second-quarter earnings or economic growth," Karyn Cavanaugh, senior market strategist at Voya Financial. "Geopolitical risks are never fun and markets tend to price in the bad news right away and the good news only gradually," Cavanaugh added.
RDI Initiates Coverage on:
Amicus Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=FOLD
Insmed, Inc.
https://rdinvesting.com/news/?ticker=INSM
Amicus Therapeutics' stock jumped 5.08% Thursday, to close the day at $15.93. The stock recorded a trading volume of 3,329,391 shares, which was above its three months average volume of 2,703,595 shares. In the last year, Amicus Therapeutics's shares have traded in a range of 7.46 - 17.40. The share price has gained 113.54% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $14.47 is at its 200-day moving average of $14.47. Shares of Amicus Therapeutics have gained roughly 15.52 percent in the past month and are up 10.70 percent year-to-date.
Access RDI's Amicus Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=FOLD
On Thursday, shares of Insmed recorded a trading volume of 450,325 shares, which was below the three months average volume of 742,635 shares. The stock ended the day 4.86% higher at 27.40. The share price has gained 138.47% from its 52-week low with a 52-week trading range of 11.49 - 33.94. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $25.08 is below its 200-day moving average of $26.96. Shares of Insmed have gained roughly 9.60 percent in the past month and are down 12.12 percent year-to-date.
Access RDI's Insmed, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=INSM
Our Actionable Research on Amicus Therapeutics, Inc. (NASDAQ :FOLD) and Insmed, Inc. (NASDAQ :INSM) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
contact@rdinvesting.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
